American Association for Cancer Research
00085472can182047-sup-204600_3_supp_5512711_pr95mh.docx (625.59 kB)

Supplementary Data from RNA Sequencing of the NCI-60: Integration into CellMiner and CellMiner CDB

Download (625.59 kB)
journal contribution
posted on 2023-03-31, 02:20 authored by William C. Reinhold, Sudhir Varma, Margot Sunshine, Fathi Elloumi, Kwabena Ofori-Atta, Sunmin Lee, Jane B. Trepel, Paul S. Meltzer, James H. Doroshow, Yves Pommier

Supplemental Figure 1. Density plot comparisons of RNA-Seq to microarray transcript data and comparison of both to DNA copy, DNA methylation and protein expression data. Supplemental Figure 2. Scatter plots for 9 selected genes for transcript expression as measured by microarray versus RNA-seq in the NCI-60. "r" is Pearson's correlation.



CellMiner ( and CellMinerCDB ( are web-based applications for mining publicly available genomic, molecular, and pharmacologic datasets of human cancer cell lines including the NCI-60, Cancer Cell Line Encyclopedia, Genomics of Drug Sensitivity in Cancer, Cancer Therapeutics Response Portal, NCI/DTP small cell lung cancer, and NCI Almanac cell line sets. Here, we introduce our RNA sequencing (RNA-seq) data for the NCI-60 and their access and integration with the other databases. Correlation to transcript microarray expression levels for identical genes and identical cell lines across CellMinerCDB demonstrates the high quality of these new RNA-seq data. We provide composite and isoform transcript expression data and demonstrate diversity in isoform composition for individual cancer- and pharmacologically relevant genes, including HRAS, PTEN, EGFR, RAD51, ALKBH2, BRCA1, ERBB2, TP53, FGFR2, and CTNND1. We reveal cell-specific differences in the overall levels of isoforms and show their linkage to expression of RNA processing and splicing genes as well as resultant alterations in cancer and pharmacologic gene sets. Gene–drug pairings linked by pathways or functions show specific correlations to isoforms compared with composite gene expression, including ALKBH2-benzaldehyde, AKT3-vandetanib, BCR-imatinib, CDK1 and 20-palbociclib, CASP1-imexon, and FGFR3-pazopanib. Loss of MUC1 20 amino acid variable number tandem repeats, which is used to elicit immune response, and the presence of the androgen receptor AR-V4 and -V7 isoforms in all NCI-60 tissue of origin types demonstrate translational relevance. In summary, we introduce RNA-seq data to our CellMiner and CellMinerCDB web applications, allowing their exploration for both research and translational purposes. The current study provides RNA sequencing data for the NCI-60 cell lines made accessible through both CellMiner and CellMinerCDB and is an important pharmacogenomics resource for the field.